Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

The divergent views on lung cancer treatments in fibrosing lung patients reflect differences due to variable side-effect incidences in different countries and among ethnicities. International efforts are needed to better define treatment approaches. https://bit.ly/3DX40fq

Detalles Bibliográficos
Autores principales: Funke-Chambour, Manuela, Kewalramani, Namrata, Machahua, Carlos, Poletti, Venerino, Wells, Athol U., Cadranel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835994/
https://www.ncbi.nlm.nih.gov/pubmed/36655227
http://dx.doi.org/10.1183/23120541.00469-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835994/
https://www.ncbi.nlm.nih.gov/pubmed/36655227
http://dx.doi.org/10.1183/23120541.00469-2022

Ejemplares similares